Registrational phase II/III trial of long-acting C-peptide (CBX129801) in patients with diabetic peripheral neuropathy.

Trial Profile

Registrational phase II/III trial of long-acting C-peptide (CBX129801) in patients with diabetic peripheral neuropathy.

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs C-peptide (Primary)
  • Indications Diabetic neuropathies
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 01 Jun 2012 Status changed from not yet recruiting to recruiting (the phase II portion of the trial is underway).
    • 25 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top